Pilot Study of RR-HNK in OCD

Recruiting Phase 1 Phase 2 Interventional Study
Obsessive-Compulsive Disorder
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Treatment
Participants needed
45 (estimated)
Sponsor
Carolyn Rodriguez · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Ages 18-65 * Meet the criteria for OCD diagnosis * Failed at least 1 prior trial of standard first-line OCD treatment (e.g. SRI/CBT) or or had refused these treatments for individual reasons * Agree to the following lifestyle modifications: comply with requirements for fasting…
Contacts

Alessa Gaeta, BA

650-723-4095

ocdresearch@stanford.edu

CONTACT